Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chuankezhi Injection for stable COPD with lung and kidney deficiency syndrome
ChiCTR-IPR-17011699Phase 4Recruiting
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Jun 2017
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of chuankezhi injection in chronic obstructive pulmonary disease (COPD) (2 arms), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Primary endpoints: Times of COPD acute attack and Hospitalization. Started Jun 2017; status: recruiting.
02
Drugs
chuankezhi injection
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on ChiCTR-IPR-17011699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-17011699.